Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease

Pediatric Nephrology

Volumn 20, Issue 3 SPEC. ISS., 2005, Pages 427-431

  Mak, Robert H ^a   Cheung, Wai ^a   Cone, Roger D ^b   Marks, Daniel L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cachexia; Chronic kidney disease; Chronic renal failure; Cytokines; Growth failure; Leptin; Melanocortin; Neuropeptide Y; Neuropeptides; Uremia

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ANOREXIGENIC AGENT; APPETITE STIMULANT; CYTOKINE; GHRELIN; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; MELANOCORTIN RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; PEPTIDE YY; PLASMA PROTEIN; PROOPIOMELANOCORTIN; TUMOR NECROSIS FACTOR ALPHA;

ACIDOSIS; ADIPOSE TISSUE; AGE; ANOREXIA; APPETITE; ARCUATE NUCLEUS; BLOOD BRAIN BARRIER; CACHEXIA; CELLULAR DISTRIBUTION; CHILD GROWTH; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE SEVERITY; ENERGY COST; EXPERIMENTATION; GROWTH DISORDER; HUMAN; HYPOTHALAMUS; HYPOTHESIS; INFLAMMATION; MALNUTRITION; METABOLIC RATE; MORBIDITY; MORTALITY; MUSCLE MASS; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; REGULATORY MECHANISM; REST; REVIEW; RISK FACTOR; SATIETY; SIGNAL TRANSDUCTION; SYNDROME; TREATMENT PLANNING; WEIGHT REDUCTION;

CACHEXIA; CHILD; CHRONIC DISEASE; CYTOKINES; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LEPTIN; MALNUTRITION; PEPTIDE HORMONES;

EID: 14644411754     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1789-1     Document Type: Review

References (48)

1. Mitch WE (2002) Malnutrition: A frequent misdiagnosis for hemodialysis patients. J Clin Invest 110:437-439 10.1172/JCI200216494
2. Mitch WE, Ramuzzi G (2004) Diets for patients with chronic kidney disease, still worth prescribing. J Am Soc Nephrol 113:115-123
3. Owen W, Lew N, Liu Y et al. (1993) The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis. New Engl J Med 329:1001-1008 10.1056/NEJM199309303291404
4. Avram M, Mittman N, Bonomini L et al. (1995) Markers for survival in dialysis. A seven-year prospective study. Am J Kidney Dis 26:209-219
5. Wong CS, Gipson DS, Gillen DL et al. (2000) Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 36:811-819
6. Wong CS, Hingorani S, Gillen Dl et al. (2002) Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630-637 10.1046/j.1523-1755.2002.00169.x
7. Holliday MA (1972) Calorie deficiency in children with uremia: Effect upon growth. Pediatrics 50:590-595
8. Kuhlmann U, Schwickardi M, Trebst R, Lange R (2001) Resting metabolic rate in chronic renal failure. J Renal Nutr 11:202-206 10.1053/ jren.2001.26981
9. Betts PR, McGrath G (1974) Growth patterns and dietary intake of children with chronic renal insufficiency. Brit Med J 2:189-193
10. Simmons JM, Wilson CJ, Potter DE, Holliday MA (1971) Relation of calorie deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation. New Engl J Med 285:653-656
11. Arnold WC, Danford D, Holliday M (1983) Effects of calorie supplementation on growth in children with uremia. Kidney Int 24:205-209 1:STN:280:BiuD3sjjsFI%3D
12. Mehls O, Ritz E, Gilli G, Bartholome K, Beibbrath H, Hohenegger M, Schafnitzel W (1980) Nitrogen metabolism and growth in experimental uremia. Int J Ped Nephrol 1:34-41
13. Mehls O, Ritz E, Hunziker EB, Eggli P, Henrich U, Zapf J (1988) Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 33:45-52 1:CAS:528:DyaL1cXovVejug%3D%3D
14. Betts PR, McGrath G, White RHR (1977) Role of energy supplementation in growth of children with chronic renal insufficiency. Brit Med J 1:416-421
15. El-Bishti M, Burke J, Gill d, Jones RW, Counahan R, Chantler C (1981) Body composition in children on regular hemodialysis. Clin Nephrol 15:53-60
16. Jones RW, Ridgen SP, Barratt TM, Chantler C (1982) The effects of chronic renal failure in infancy on growth, nutritional status and body composition. Pediatr Res 16:784-791
17. Daschner M, Tonshoff B, Blum WF et al. (1998) Inappropriate elevation of serum leptin in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 9:1074-1079
18. Schwartz MW, Morton GJ (2002) Obesity: Keeping hunger at bay. Nature 418:595-597 10.1038/418595a
19. Batterham RL, Cowley MA, Small CJ et al. (2002) Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654 10.1038/ nature00887
20. Tisdale MJ (1997) Biology of cachexia. J Natl Cancer Inst 89:1763-1773
21. Larkin M (1998) Thwarting the dwindling progression of cachexia. Lancet 351:1336 10.1016/S0140-6736(00)80032-X
22. Inui A (1999) Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer Res 59:4493-4501
23. Kotler DP, Tierney AR, Wang J, Pierson RNJ (1989) Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50:444-447 1:STN:280:BiaA2s7ls1Y%3D
24. Plata-Salaman CR (1989) Immunomodulators and feeding regulation: A humoral link between the immune and nervous systems. Brain Behav Immunol 3:193-213 10.1016/0889-1591(89)90036-6
25. Plata-Salaman CR, Borkoski JP(1994) Chemokines/intercrines and central regulation of feeding. Am J Physiol 275:R1711-R1715
26. Sherry BA, Gelin J, Fong Y, Marano M, Wei H, Cerami A, Lowry SF, Lundholm KG, Moldawer LL (1989) Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J 3:1956-1962
27. Fong Y, Moldawer LL, Marano M et al. (1989) Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 256(3 Pt 2):R659-RG65 1:CAS:528:DyaL1MXitFSmurY%3D
28. Plata-Salaman CR, Sonti G, Borkoski JP, Wilson CD, French-Mullen JM (1996) Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol Behav 60(3):867-875 10.1016/S0031-9384(96)00148-5
29. Marks DL, Ling N, Cone RD (2001) Role of central melanocortin system in cachexia Cancer Res. 61:1432-1438
30. Ahima RS, Staels B (2000) Leptin. Ann Rev Physiol 62:413-437 10.1146/ annurev.physiol.62.1.413
31. Halaas J, Gajiwala K, Maffei M et al. (1995) Weight-reducing effects of plasma protein encoded by the obese gene. Science 269:543-549
32. Sharma K, Considine RV, Michael B et al. (1997) Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51(6):1980-1985
33. Johansen KL, Mulligan K, Tai V, Schambelan M (1998) Leptin, body composition and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 9:1080-1984
34. Stenvinkel P, Heimburger O, Lonnqvist F (1997) Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transpl 12:1321-1325 10.1093/ndt/12.7.1321
35. Pecoits-Filho R, Nordfors L, Heimburger O, Lindholm B, Anderstam B, Marchlewska A, Stenvinkel P (2002) Soluble leptin receptors and serum leptin in end-stage renal disease: Relationship with inflammation and body composition. Eur J Clin Invest 32:811-817 10.1046/ j.1365-2362.2002.01063.x
36. Wolf G, Chen S, Han DC, Ziyadeh FN (2002) Leptin and renal disease. Am J Kidney Dis 39:1-11 10.1053/ajkd.2002.32799
37. Yoshimoto A, Mori K, Sugawara A et al. (2002) Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13:2748-2752
38. Rodriguez Ayala E, Pecoits-Filho R, Heimburger O, Lindholm B, Nordfors L, Stenvinkel P (2004) Associations between plasma ghrelin levels and body composition in end-stage renal disease: A longitudinal study. Nephrol Dial Transpl 19:421-426 10.1093/ndt/gfg559
39. Stenvinkel P, Pecoits-Filho R, Lindholm B (2003) Leptin, ghrelin and proinflammatory cytokines: Compounds with nutritional impact in chronic kidney disease? Advances Renal Replace Th 10:332-345 10.1053/ j.arrt.2003.08.009
40. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B (1990) Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 37(1):116-125
41. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32(1):107-114
42. Goodman MN (1994) Interleukin-6 induces skeletal muscle protein breakdown in rats. P Soc Exp Biol Med 205:182-185
43. Tsujinaka T, Fujita J, Ebisuri C et al. (1996) Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in Interleukin 6 transgenic mice. J Clin Invest 97:244-249 1:CAS:528:DyaK28Xhtlaisrc%3D
44. Aguilera A, Codoceo R, Selgas R et al. (1998) Anorexigen (TNF alpha, cholecystokinin) and orexigen (neuropeptide Y) in peritoneal dialysis patients. Their relationship with nutritional parameters. Nephrol Dial Transpl 13:1476-1483 10.1093/ndt/13.6.1476
45. Guttridge DC, Mayo MW, Madrid LV et al. (2000) NF-κB induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia. Science 289:2363-2365 10.1126/science.289.5488.2363
46. Plata-Salaman CR (1998) Cytokines and anorexia: A brief overview. Semin Oncol 25:4-11 1:CAS:528:DyaK1cXjvVCkt70%3D
47. Airaghi L, Garofalo L, Cutuli MG et al. (2000) Plasma concentrations of alpha melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis. Nephrol Dial Transpl 15:1212-1216 10.1093/ndt/15.8.1212
48. Cheung W, Marks DL, Yu PX, Cone RD, Mak RH (2003) Role of the central melanocortin system in the cachexia of uremia. J Am Soc Nephrol 14:326A